Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | PRCP | P42785 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4072745 | 0.90 | PRCP (0.49) | ALDH1A1KDM4EPRCPNPY2RTHRB | |
| SCHEMBL4695183 | 0.88 | PRCP (0.52) | KDM4EPRCP | |
| SCHEMBL4253158 | 0.88 | PRCP (0.55) | ALDH1A1KDM4EPRCPNPY2R | |
| SCHEMBL14282927 | 0.87 | BACE1 (0.52) | ALDH1A1KDM4ENPY2RLMNA | |
| SCHEMBL4254317 | 0.84 | BCHE (0.59) | LMNAEGFR | |
| SCHEMBL12123733 | 0.84 | PRCP (0.55) | KDM4EPRCP | |
| SCHEMBL14282941 | 0.84 | PRCP (0.54) | KDM4EPRCPLMNA | |
| Hydrochloric Acid SCHEMBL9356588 | 0.83 | BCHE (0.58) | ALDH1A1THRBLMNAEGFRKMT2A | |
| SCHEMBL9353361 | 0.83 | KDM4E (0.46) | ALDH1A1KDM4EPRCPTHRBLMNA | |
| Hydrochloric Acid SCHEMBL9352843 | 0.82 | ALDH1A1 (0.45) | ALDH1A1KDM4EPRCPTHRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7317026-B2 | Sleep disorders; side effect reduction ; antihistamine antagonist | HYPNION, INC. (US) | 2008-01-08 | — | — | US | disclosed |